Encision Inc. ECIA

What this company does

We believe that our patented Active Electrode Monitoring (AEM®) Surgical Instruments are changing the marketplace for electrosurgical devices and laparoscopic instruments by providing a solution to a well-documented hazard unique to laparoscopic surgery. We have been issued 21 unexpired patents relating to AEM technology from the United States Patent and Trademark Office, each encompassing multiple claims, and which have between one and twenty years remaining. We also have patents on AEM technology in Europe, Japan, Canada, and Australia. The electrosurgical device market is intensely competitive and tends to be dominated by a relatively small group of large and well-financed companies. We compete directly for customers with those companies that currently make conventional electrosurgical instruments. Larger competitors include Advanced Surgical Technologies Group (a division of Medtronic plc) and Ethicon Endo-Surgery (a division of Johnson & Johnson).

Written from the business description in Encision Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 10 July 2025. Every sentence was checked against that document before publication.